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1. Introduction 
12-O-Tetradecanoyl-phorbol-13-acetate (TPA) isa 
potent umor-promoting a ent in carcinogenesis of
mouse skin and also has various biological activities 
[ 1 ]. Recent studies concerning the activity of TPA 
have been extensively performed by using in vitro cul- 
tured cells. For example, TPA-treated fibroblast and 
epidermal cells produced specific proteins [2-4]. 
However, the biological activities of these proteins 
have not been elucidated. There are several reports 
that TPA stimulates lymphoid cells to produce various 
factors which regulate immune responses: interleukin 1 
and 2 [5,6]. Thus, TPA-treated fibroblast cells may 
produce factors which influence immune responses. 
Here, we show that TPA-treated fibroblast cells pro- 
duce several factors which regulate thymocyte DNA 
synthesis and discuss the physiologica! significance of 
these factors. 
2. Materials and methods 
3T3 fibroblast cells were obtained from Dr S. 
Kurata (Department of Radiation Biology and Health, 
University of Occupational nd Environmental Health) 
and maintained invitro culture in RPMI 1640 medium 
(Grand Island Biological Co.-Gibco) supplemented 
with 100/~g streptomycin/ml, 100 units penicillin/ml 
and 5% fetal calf serum (FCS, Gibco). This cell line 
becomes confluent usually in 3 days by 1:5 ratio split. 
The confluent cultured cells were washed once with 
RPMI 1640 medium and TPA or other phorbol esters 
were added at a final concentration f 100 ng/ml in 
RPMI 1640-FCS 5%. After incubation at 37°C for 
8 h, the culture supernatant was collected and concen- 
trated by salting out with 60% of (NH4)2SO4 (pH 7.5). 
After centrifugation at 16 000 rev./min for 15 min by 
a Beckman JA-20 rotor, the precipitate was dissolved 
in 1.5 ml 10 mM phosphate-buffered saline (PBS) 
(pH 7.2), applied on a Sephadex G-100 column 
(1.8 X 24 cm), and eluted with 10 mM PBS (pH 7.2). 
In the case of trypsin digestion experiment, the origi- 
nal sample was dialyzed against PBS (pH 7.2), incu- 
bated with trypsin (25/ag]ml) at 30°C for 30 min and 
fractionated by the same Sephadex G-100 column. 
Thymocyte proliferation assay was performed by a 
modification of the method in [7]: 2.5 × l0 s thymo- 
cytes of C3H/He mice were cultured in vitro with 
2.5/ag/ml of concanavalin A (con A) in 0.2 ml RPMI 
1640-FCS 5% in wells of microtiter culture plates 
(Falcon no. 3042) at 37°C in 5% CO2 and 95% air for 
2 days. The culture supernatant of3T3 flbroblast cells 
or each fraction from the gel filtration was added 
at 50% final cone. The cells were labeled with 1/~Ci 
[3H]thymidine (5 Ci/mmol, Radiochemical Center, 
Amersham) for 24 h and harvested by an aid of auto- 
marie cell harvester (Abe Kagaku Co.). Thymidine 
incorporated into thymocytes was counted by a 
Beckman liquid scintillation counter. The results were 
expressed as means and standard errors of cpm/well of 
triplicate assays. 
3. Results and discussion 
A culture supematant of TPA-treated 3T3 fibro- 
blast cells strongly enhanced con A-dependent [3H]- 
thymidine incorporation of mouse thymocytes a
compared with that of untreated cells (table 1). This 
supernatant had no effect on thymocyte r sponse 
Published by Elsevier Biomedical Press 
00145793/82/0000-0000/$02.75 © 1982 Federation ofEuropean Biochemical Societies 93 
Volume 142, number 1 FEBS LETTERS June 1982 
Table 1 
Effects of various phorbol esters on the induction of 
lymphocyte activating factors 
3T3 fibroblast 
stimulated with 
[ 3H]Thymidine incorporation (cpm) 
Con A (-) Con A (+) 
- 607 +- 235 5755 -+ 456 
Phorbol 1425 -+ 495 17 799 +_ 1609 
Phorbol myristate 296 _+ 49 11 364 _+ 1098 
Phorbol-13-acetate 1520 +- 501 9994 +_ 1414 
TPA 396 -+ 136 99 141 _+ 3611 
without con A. Culture supernatants of 3T3 ceils 
treated with other phorbol esters; phorbol, phorbol- 
12-monomyristate, phorbol-13-monoacetate showed 
considerable effects on con A-dependent thymocyte 
response. But, TPA showed the strongest effect 
amongst various phorbol esters. These results uggest 
that TPA-treated fibroblast cells produce thymocyte- 
activating factors. 
To investigate the nature of thymocyte activating 
factors, we performed Sephadex G-100 column chro- 
matography. In the case of TPA-treated ceils, the acti- 
vating factors were fractionated into 2 major peaks 
(fig.l); one is a sharp peak at ~13 000 Mr; the other 
is a slightly broad peak at ~30 000M r (fig.lb). In 
contrast, these activities could not be detected in 
untreated cells (fig.la). Furthermore, some inhibitory 
activities were detected at the positions at 100 000 M r 
and 1500 M r. When the factors were partially digested 
by trypsin treatment (25/~g/ml, 30 min at 30°C) 
before the application to the gel filtration, the activi- 
ties of these factors were decreased and appeared at 
lower M r levels (fig.2). The activity of the 13 000 M r 
peak seems to be relatively sensitive to trypsin treat- 
ment as compared with that of the 30 000 M r peak. 
We investigated the heat sensitivity of these factors. 
The activity at 30 000M r peak was lost considerably 
(~50% of control activity) by the treatment at 90°C 
for 5 min, but the peak at 13 000 M r was relatively 
resistant under the same conditions. This result sug- 
Fig.2. Sephadex G-100 column chromatography of TPA- 
treated 3T3 fibroblast culture supernatant af er the trypsin 
digestion. The same amount of the sample in riga was par- 
tially digested with trypsin treatment (25 tzg/ml, 30 min at 
30 ° C) and fraetionated by the same procedures. The experi- 
mental conditions of other procedures and representation in 
the figure axe the same as those of fig.1. 
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Fig.1. Sephadex G-100 column chromatography of culture 
supernatants from untreated (a) and treated (b) 3T3 fibroblast 
cells. The sample was collected from 30 ml culture superna- 
tant as in section 2: (o - -o )  cpm [ 3H] thymidine incorpora- 
tion of thymocytes stimulated with con A; (e - -e )  absorb- 
ance at 280 nm. Arrows in the figure represent positions of 
bovine serum albumin (67 000 Mr) , horseradish peroxidase 
(40 000 Mr) , cytochrome c (13 500 Mr), insulin (5700 Mr) 
and bacitracin (1500 Mr) as marker proteins from the left to 
the right. 
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gests that these activating factors are proteins and 
that their properties are considerably different from 
each other. 
Some researchers have reported the production of 
specific proteins by TPA-treated fibroblast or epider- 
mis: in [2], 13 500M r and histidine-rich 27 000M r 
proteins were found at 12-48 h after TPA treatment 
on epidermal cells [2]; in [3] secretion of 35 000 M r 
glycoprotein by TPA-treated 3T3 fibroblast cells was 
reported; in [4] synthesis of 41 000M r protein by 
mouse epidermis was shown. However, the physiologi- 
cal significance of these proteins has not been eluci- 
dated. The factors reported here may correspond to 
the specific proteins in [2--4]. TPA stimulates the pro- 
duction of interleukins by macrophages (15 000 Mr) 
[5] and T cells (~30 000Mr) [6]. A similar factor 
(15-25 000 Mr) was found in murine keratinocyte 
which stimulates PHA-dependent thymocyte DNA 
synthesis [8]. 
Although the relationship between interleukins 1
and 2, keratinocyte factor and the factors derived 
from fibroblast remains unknown, this evidence sug- 
gests that fibroblast also regulates lymphocyte 
responses and may play some roles in the complex 
immune networks. 
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